id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-N-0344-0003,FDA,FDA-2009-N-0344,Microbiology Devices: Reclassification of Herpes Simplex Virus Types 1 and 2 Serological Assays; Confirmation of Effective Date,Rule,NCD-Notice of Confirmation of Effective Date,2010-09-28T04:00:00Z,2010,9,2010-09-28T04:00:00Z,,2010-09-28T14:23:52Z,2010-23638,0,0,0900006480b62224
FDA-2009-N-0344-0002,FDA,FDA-2009-N-0344,Microbiology Devices; Reclassification of Herpes Simplex Virus Types 1 and 2 Serological Assays,Rule,NFR-Notice of Final Rule,2009-08-25T04:00:00Z,2009,8,2009-08-25T04:00:00Z,2009-11-10T04:59:59Z,2009-08-25T17:11:12Z,E9-20411,0,0,0900006480a11be7
FDA-2009-N-0344-0001,FDA,FDA-2009-N-0344,Microbiology Devices; Reclassification of Herpes Simplex Virus Types 1 and 2 Serological Assays,Proposed Rule,NPR-Notice of Proposed Rule-Making,2009-08-25T04:00:00Z,2009,8,2009-08-25T04:00:00Z,2009-11-10T04:59:59Z,2009-08-25T17:04:40Z,E9-20415,0,0,0900006480a11bd7